ACTIVE

Anesthesie-Intensieve Geneeskunde-Urgentiegeneeskunde-Pijncentrum ZOL

Financial year 2025 · Closed on 31/12/2025

Net result-9 k €-108,5 %over 1 year
Gross margin-4 k €-102,6 %over 1 year
Equity152,4 k €-5,4 %over 1 year

Identity

Source · BCE/KBO

Anesthesie-Intensieve Geneeskunde-Urgentiegeneeskunde-Pijncentrum ZOL is a Private limited company incorporated in 2018. Its main activity is: Specialist medical practice activities. Its registered office is in Genk.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0691.654.144
Incorporation
01/03/2018
Legal form
Private limited company
Registered office
Weg naar As 141 box 1
3600 Genk · FlandreSee on map
Contributed capital
8 800,00 €
Latest accounts
31/12/2025
Signals
Solid equityLow riskGood liquidity

Financials

Source · NBB, 8 filings

Trend over 8 financial years

20252024202320222021
Income statement
Gross margin-4 k €154,4 k €7,3 k €43,8 k €-5,8 k €
EBITDA-6,4 k €153,7 k €6 k €43 k €-6,2 k €
Operating result-6,4 k €153,7 k €6 k €43 k €-6,2 k €
Net result-9 k €106,2 k €614 €34,5 k €-9,3 k €
Balance sheet
Equity152,4 k €161,1 k €54,8 k €54,4 k €19,7 k €
Total assets205,9 k €214,7 k €60,4 k €66,1 k €210,7 k €
Cash52,6 k €67,4 k €52 k €16,9 k €210,7 k €
Debts52,9 k €53,3 k €5,2 k €11,1 k €3,6 k €

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

8 active · 6 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
COYS GENK0816.559.064Represented by Pieter De Vooght
Director01/01/2025 → 31/12/2030
DIMEDRIC0676.714.857Represented by Dieter Mesotten
Director01/01/2025 → 31/12/2030
DR. JAN VAN ZUNDERT0463.607.738Represented by Jan Van Zundert
Director01/01/2025 → 31/12/2030
Dr. Jente Grietens0728.919.762Represented by Jente Grietens
Director01/01/2025 → 31/12/2030
Dr. Tanghe Ignace0461.179.075Represented by Ignace Tanghe
Director12/02/2019 → 31/12/2030
DR. THIESSEN STEVEN, ANESTHESIE0747.757.459Represented by Steven Thiessen
Director01/01/2025 → 31/12/2030
GOFI0741.396.833Represented by Tom Fivez
Director01/01/2025 → 31/12/2030
PURAM0695.859.885Represented by Pieter-Jan Van Asbroeck
Director01/01/2025 → 31/12/2030

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Klinisch biologe Dr. VAN dER bEEK DANIELLE0543.591.067Represented by Jeroen Van Melkebeek
Director01/01/2025 → 31/12/2030
A&E0440.535.396
Director

Other companies at this address

Weg naar As 141 3600 Genk
CompanyCBE no.
D. ALGUT● Active
0743.917.744

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date08/07/202627/06/202527/06/202403/07/202318/07/202231/08/2021
General meeting25/06/202626/06/202524/06/202419/06/202316/06/202225/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 8 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202525/06/202608/07/2026DutchPDF
Micro model31/12/202426/06/202527/06/2025DutchPDF
Micro model31/12/202324/06/202427/06/2024DutchPDF
Micro model31/12/202219/06/202303/07/2023DutchPDF
Micro model31/12/202116/06/202218/07/2022DutchPDF
Micro model31/12/202025/06/202131/08/2021DutchPDF
Abridged model31/12/201925/06/202024/07/2020DutchPDF
Micro model31/12/201825/06/201918/07/2019DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

8 active · 6 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
COYS GENK0816.559.064Represented by Pieter De Vooght
Director01/01/2025 → 31/12/2030
DIMEDRIC0676.714.857Represented by Dieter Mesotten
Director01/01/2025 → 31/12/2030
DR. JAN VAN ZUNDERT0463.607.738Represented by Jan Van Zundert
Director01/01/2025 → 31/12/2030
Dr. Jente Grietens0728.919.762Represented by Jente Grietens
Director01/01/2025 → 31/12/2030
Dr. Tanghe Ignace0461.179.075Represented by Ignace Tanghe
Director12/02/2019 → 31/12/2030
DR. THIESSEN STEVEN, ANESTHESIE0747.757.459Represented by Steven Thiessen
Director01/01/2025 → 31/12/2030
GOFI0741.396.833Represented by Tom Fivez
Director01/01/2025 → 31/12/2030
PURAM0695.859.885Represented by Pieter-Jan Van Asbroeck
Director01/01/2025 → 31/12/2030

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Klinisch biologe Dr. VAN dER bEEK DANIELLE0543.591.067Represented by Jeroen Van Melkebeek
Director01/01/2025 → 31/12/2030
A&E0440.535.396
Director

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Other06/07/2026
    —
    PDF
  • Mandates04/12/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - MAATSCHAPPELIJKE ZETEL - DOEL - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates25/06/2019
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other05/03/2018
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings8 filings
Mandates
Dr. Tanghe Ignace
DR. JAN VAN ZUNDERT
DIMEDRIC
PURAM
Dr. Jente Grietens
GOFI
DR. THIESSEN STEVEN, ANESTHESIE
COYS GENK
Klinisch biologe Dr. VAN dER bEEK DANIELLE
2018201920202021202220232024202520262027202820292030
ANIGUP - Anesthesie-Intensieve Geneeskunde-Urgentiegeneeskunde-Pijncentrum ZOLAnesthesie-Intensieve Geneeskunde-Urgentiegeneeskunde-Pijncentrum ZOL
Weg naar As 141 bte 1, 3600 GenkWeg naar As 155, 3600 Genk
Director
Director
Director
Director
Director
Director
Director
Director
Director
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Weg naar As 141 bte 1, 3600 GenkCurrent
accounts 2024 → 2025
Accounts 2025 · 2026-00267980
Weg naar As 155, 3600 Genk
accounts 2021 → 2023
Accounts 2023 · 2024-00168395

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
Anesthesie-Intensieve Geneeskunde-Urgentiegeneeskunde-Pijncentrum ZOLCurrent
CBE
ANIGUP - Anesthesie-Intensieve Geneeskunde-Urgentiegeneeskunde-Pijncentrum ZOL
accounts 2021 → 2025
Accounts 2025 · 2026-00267980
Anesthesie-Intensieve Geneeskunde-Urgentiegeneeskunde-Pijncentrum ZOL
accounts 2018 → 2020
Accounts 2020 · 2021-62900260

Events

  1. 2025
    Annual accounts 2025-9 k €↓
  2. 2024
    Annual accounts 2024106,2 k €↑
  3. 2023
    Annual accounts 2023614 €↓
  4. 2022
    Annual accounts 202234,5 k €↑
  5. 2021
    Annual accounts 2021-9,3 k €↓
  6. 2021
    Name changeANIGUP - Anesthesie-Intensieve Geneeskunde-Urgentiegeneeskunde-Pijncentrum ZOL
  7. 2020
    Annual accounts 2020623 €↑
  8. 2019
    Annual accounts 2019-6 €↓
  9. 2018
    Annual accounts 201820 k €
  10. 01/03/2018
    IncorporationPrivate limited company